By Sarah LoBisco, ND
Whew, uh-oh….the controversy continues. Recently, the FDA issued 4 new changes to Statin medications, drugs which lower cholesterol levels. This created debate in medicine as to the risk-benefit ratio of these medications. I wrote in various blogs about cholesterol and have provided an update on my recent blog at Saratoga.com. [...]
Let’s Connect